ディゴキシン製品品質の評価に関する溶解方法の適切性
Rizwan Shaikh1, Swaroop J Pansare1, Bhanu P Dongala1
1Irma Lerma Rangel College of Pharmacy, Texas A&M Health Science Center, Texas A&M University, College Station, TX, USA.
AAPS PharmSciTech
|February 23, 2026
まとめ
新しいUPLC方法は,ディゴキシン (DGX) と不純物質を正確に定量化します. ディゴキシン錠剤はUSP検査および水中の溶解基準を満たしたが,酸に分解し,安定性の問題は溶解に影響した.
科学分野:
- 医薬品分析 医薬品分析について
- 薬剤品質管理 薬剤品質管理について
背景:
- ディゴキシン (DGX) は,厳格な品質管理を必要とする重要な医薬品です.
- 既存の分析方法では,DGXタブレットの品質と安定性を適切に評価できない可能性があります.
研究 の 目的:
- DGXおよびその不純物に対するUPLCメソッドを同時に開発し,検証する.
- 商業用DGXタブレットの溶解プロフィールを比較する.
- 開発された方法を使用してDGXタブレットの品質と安定性を評価します.
主な方法:
- ICHガイドラインによるUPLCの方法開発と検証.
- 検定および溶解試験を含む品質評価.
- 加速された条件 (30°C/75%RH,40°C/75%RH) の安定性研究.
- 水と0.1N HCl.に溶解する試験
- 結晶性分析のためのX線粉の difraktion.
主要な成果:
- UPLC法では,DGXと主要な不純物について,特異性,線形性 (100-2000 ng/ml),精度 (>98.6%),精度 (<3.3%) を示した.
- DGX錠剤は,測定量 (>98%) と溶解量 (>85% 20分で水中に溶解) のUSP仕様を満たしました.
- 退廃は酸性環境で発生し,光スペクトロメトリー法では特異性が欠けていた.
- 安定性研究では,溶解が約30%減少し,結晶性が増加し,USPの仕様には適合しないことが示されました.
結論:
- 開発されたUPLC方法は,DGXタブレット品質の評価に適しています.
- 酸性介質での溶解試験と光スペクトロメトリクアッセイは,通常のQCに対して非特異的で差別的ではない.
- 安定性は,DGX錠剤の溶解と物理的性質に大きく影響する.
キーワード:
結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,結晶度 (Crystallinity) とは,ディゴキシン (Digoxin) とは解散 解散 解散するスペクトロフローロメーターは,安定性の安定性とは検証 検証 検証関連する概念動画
Drug Dissolution: Requirements and Profile Comparison
337
The acceptance criteria for dissolution profile data are anchored in Q values, representing the percentage of drug dissolved within a specified period. This assessment unfolds in three stages:First Stage: The test passes if all six drug dosage units are equal to or greater than Q plus 5%; otherwise, the sample proceeds to the second stage.Second Stage: The average of twelve units must be equal to or greater than Q, with no unit falling below Q - 15% to pass; if not, it progresses to the final...
337
In Vitro Drug Dissolution: Compendial Testing Models I
369
Compendial dissolution methods are standardized procedures defined by pharmacopeias to evaluate the rate at which a drug dissolves in a specific medium. These methods ensure batch-to-batch consistency, enable quality control, and support the prediction of drug bioavailability. They are critical for both immediate and modified-release drug products.The apparatuses used for dissolution testing differ in their design and mechanical function, but all aim to simulate the physiological environment of...
369
In Vitro Drug Dissolution: Compendial Testing Models II
399
Various dissolution methods are utilized to assess a drug’s dissolution rate, including the flow-through cell, paddle-over-disk, cylinder, and reciprocating disk methods.The flow-through cell apparatus (USP (United States Pharmacopeia) method 4) comprises a reservoir for the dissolution medium and a pump that propels the medium through the cell containing the test sample. This method is crucial for assessing modified-release dosage forms with minimally soluble active ingredients,...
399
In Vitro Drug Dissolution: Alternative Methods
290
Alternative drug dissolution methods include the rotating bottle, intrinsic dissolution test, peristalsis, and the Franz diffusion cell method. The rotating bottle method involves meticulously rotating tightly capped controlled-release beads in a temperature-controlled bath. Periodic decanting of samples allows for residue assay, followed by refilling with fresh medium and testing at various pH levels to emulate the gastrointestinal tract conditions.In contrast, the intrinsic dissolution test...
290
Clinically Relevant Drug Product Specifications: Methods of Establishment
273
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
273
In Vitro Drug Release Testing: Overview, Development and Validation
422
In vitro dissolution and drug release tests assess how quickly and how much of a drug is released from its dosage form into an aqueous medium under standardized laboratory conditions. These tests are essential tools in pharmaceutical development and quality assurance, offering insight into the drug's performance before clinical use.During formulation development, dissolution testing identifies incomplete or inconsistent drug release issues. It also supports decisions on selecting the optimal...
422


